MedPath

A prospective study of the usefulness of liquid biopsy as biomarker during diagnosis and treatment for the cervical cancer

Not Applicable
Recruiting
Conditions
cervical cancer
Registration Number
JPRN-UMIN000027121
Lead Sponsor
Wakayama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

The patients are followed our protocol.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation between gene mutation by liquid biopsy and progression free survival.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath